Tumor-infiltrating lymphocytes (TIL) therapy represents a groundbreaking advancement in treating of solid tumors, leveraging the body's immune system to target and eliminate cancerous cells. This therapy involves extracting TILs from a patient's tumor, expanding them ex vivo, and infusing them to fortify the body's natural defenses against malignancies.
